Autopsy report · NCT05220306

AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation

“No eligible patients could be found and funding was lost”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

AIDAR Health, Inc.

Sponsor type

Industry

Conditions

Sars-CoV-2 Infection

Interventions

Monitoring of vital signs

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors
  “Lack of additional funding; patients (3) no longer receiving intervention.” (77% match in meaning)
• Safety and Effectiveness of Combined LED Light for the Treatment of Mild to Moderate Plaque Type Psoriasis Vulgaris
  “Lack of funding and sponsor decided to not pursue clinical trial” (73% match in meaning)
• The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
  “no eligible patient” (73% match in meaning)
• Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis
  “no patients were included” (73% match in meaning)
• QLESP Block in Hip Surgery
  “No patients enrolled” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.